Loading...
•
Mar 31, 2021
Conmed Q1 2021 Earnings Report
Reported positive first-quarter performance due to team's perseverance and increased full-year guidance.
Key Takeaways
CONMED Corporation announced positive first-quarter results, driven by the team's perseverance in a challenging environment. The company is increasing its full-year 2021 revenue guidance to between $1.0 billion and $1.03 billion and adjusted diluted net earnings per share to a range of $3.05 to $3.20.
CONMED's first-quarter performance was strong, reflecting the team's dedication.
The company is well-positioned to benefit from an improving surgical landscape.
Full-year 2021 revenue guidance has been raised to $1.0 to $1.03 billion.
Full-year 2021 adjusted diluted net earnings per share are now projected to be in the range of $3.05 to $3.20.
Conmed
Conmed
Forward Guidance
CONMED is increasing its guidance for full-year 2021 revenue and adjusted diluted net earnings per share.
Positive Outlook
- Revenue is expected to be between $1.0 billion and $1.03 billion.
- Positive impact to 2021 sales from foreign exchange is expected.
- Adjusted diluted net earnings per share in the range of $3.05 to $3.20.
- Company is well-positioned to capitalize on an improving surgical landscape
- Team’s ability to provide innovative solutions
Challenges Ahead
- Risks posed to the Company’s business, financial condition, and results of operations by the COVID-19 global pandemic
- Deferral of surgeries
- Reductions in hospital and ambulatory surgery center operating volumes
- Disruption to potential supply chain reliability
- General industry and economic conditions